Article metrics

Download PDFPDF

558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to December 2022

AbstractFullPdf
Nov 2022945061
Dec 2022242016
Total1187077